Health systems should continue to be regulated at national level
EU member states are responsible for the organisation of their healthcare systems. Nevertheless, legislative developments at European level can have a significant direct or indirect impact on private health insurers with a significant direct or indirect impact on private health insurers, such as in their use of genetic information, for example.
There is continued scrutiny about the use of genetic information by health insurers in the EU, even though insurers generally do not use or ask for predictive genetic test results, except in very specific cases that are defined and regulated at national level.
Insurance Europe believes that it would be difficult for any EU-level regulation on the use of genetic information — or indeed of many other health-related issues — to capture the existing diversity in national markets.